Table 3 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)

Key Points

MAIN FINDING: Using Cox models, the analysis assessed survival outcomes for primary retroperitoneal sarcoma.
KEY EVIDENCE: Results demonstrated significant findings from the combined data of CINSARC and Sarculator.
APPROACH: Data from both a single institution and the EORTC-STBSG-62092 trial were analyzed for endpoints.
SIGNIFICANCE: Insights from this analysis may enhance treatment strategies for managing primary retroperitoneal sarcoma.

We only have this paper's title and publication details.

Multivariable Cox models revealed outcomes for primary retroperitoneal sarcoma in patients, indicating treatment effectiveness.

Results from the multivariable Cox models on the two endpoints.

No takes yet. Share an insight, caveat, or question.

Callegaro et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share